Prevalence of c-myc expression in breast lesions associated with microcalcifications detected by routine mammography

Genetic abnormalities in cell proliferation-regulating genes have been described in premalignant lesions. The aims here were to evaluate c-myc protein expression in non-palpable breast lesions associated with microcalcifications, detected by screening mammography, and to compare these results with h...

Full description

Saved in:
Bibliographic Details
Published inSão Paulo medical journal Vol. 127; no. 2; pp. 66 - 70
Main Authors Mazzini, Renato Coimbra, Elias, Simone, Nazário, Afonso Celso Pinto, Kemp, Cláudio, Logullo, Angela Flávia
Format Journal Article
LanguageEnglish
Portuguese
Published Brazil Associação Paulista de Medicina - APM 01.05.2009
Associação Paulista de Medicina
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Genetic abnormalities in cell proliferation-regulating genes have been described in premalignant lesions. The aims here were to evaluate c-myc protein expression in non-palpable breast lesions associated with microcalcifications, detected by screening mammography, and to compare these results with histopathological, clinical and epidemiological variables. Analytical cross-sectional study, with retrospective data collection, in a university hospital in São Paulo. Seventy-nine female patients who underwent routine mammography between 1998 and 2004 were studied. Lesions classified by the Breast Imaging Reporting and Data System (BI-RADS) as 4 or 5 underwent percutaneous biopsy using a large-core needle. Ninety-eight lesions were studied anatomopathologically. Paraffin blocks properly representing the lesions were selected for immunohistochemical analyses using the streptavidin-biotin-peroxidase technique with monoclonal mouse c-myc antibodies. Among the 98 lesions, 29 (29.6%) contained malignant neoplasia; 40 (40.8%) had a positive immunohistochemical reaction for c-myc. When the groups were divided between lesions without atypias versus atypical lesions plus malignant lesions, 31.03% of the 58 lesions without atypias were positive for c-myc and 55% of the 40 malignant and atypical lesions (P = 0.018). Comparing the atypical lesions with ductal carcinoma in situ versus the benign lesions without atypias, c-myc was present in 51.61% of the 31 atypical lesions and 31.03% of the benign lesions without atypias (P = 0.057). C-myc protein was more frequently expressed in atypical and malignant lesions than in benign lesions without atypias. C-myc expression correlated with the presence of atypias (P = 0.018).
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Conflict of interest: None
ISSN:1516-3180
1806-9460
1806-9460
1516-3180
DOI:10.1590/s1516-31802009000200003